1
van Hulst, Marinus, Stevanovic, Jelena, Jacobs, Maartje S, Tieleman, Robert G, Kappelhoff, Bregt, Postma, Maarten J
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
2
Stevanovic, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
3
4
5
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
6
van Leent, Merlijn W. J., Stevanovic, Jelena, Jansman, Frank G., Beinema, Maarten J., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015